The Longevity Fund

The Longevity Fund backs startups developing therapies to extend healthy lifespan. It operates as a venture capital firm investing in seed and Series A companies across life sciences, digital health, oncology, and impact investing. The firm focuses on longevity as a field and supports mission-driven founders navigating regulatory and fundraising challenges. Through age1, the Longevity Fund's successor, it continues longevity investing with a history of helping portfolio companies reach clinical trials and IPOs. The portfolio has raised over $1B, launched five IPOs, and advanced multiple programs addressing aging to the clinic.